Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Bellevue Funds Lux - BB Biotech

+ Add to Watchlist

M0U2:GR

459.9400 EUR 6.1770 1.33%

As of 10:15:42 ET on 02/26/2015.

Snapshot for Bellevue Funds Lux - BB Biotech (M0U2)

Open: 456.4900 High - Low: 463.0590 - 454.6700 Primary Exchange: Frankfurt
Volume: 26 52-Week Range: 218.5200 - 466.1170 Beta vs DAX: 0.6600

ETF Chart for M0U2

No chart data available.
  • M0U2:GR 463.0590
  • 1D
  • 1M
  • 1Y
466.1170
Interactive M0U2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for M0U2

Bellevue Funds (Lux) - BB Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector. The focus is on companies that develop, research, and market various technologies and products in this sector.

Inception Date: 2009-03-31 Telephone: 41-44-267-67-00
Managers: DANIEL KOLLER
Web Site: www.bellevuegroup.com

Fundamentals for M0U2

NAV -
Assets (M) (on 2015-02-25) 96.0926
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for M0U2

No dividends reported

Performance for M0U2

1-Month +4.49% 1-Year +58.27%
3-Month +27.23% 3-Year +51.22%
Year To Date +22.44% 5-Year +31.62%
Expense Ratio -

Top Fund Holdings for M0U2

Filing Date: 12/31/2014
Name Position Value % of Total
Gilead Sciences Inc 64,526 6,082,221 8.831%
Celgene Corp 51,964 5,812,693 8.439%
Biogen Idec Inc 16,000 5,431,200 7.886%
Amgen Inc 30,866 4,916,645 7.139%
Vertex Pharmaceuticals Inc 28,500 3,385,800 4.916%
Regeneron Pharmaceuticals Inc 7,595 3,115,849 4.524%
Medivation Inc 29,300 2,918,573 4.237%
Alexion Pharmaceuticals Inc 15,746 2,913,482 4.230%
Incyte Corp 36,352 2,657,695 3.859%
Mylan Inc/PA 43,779 2,467,822 3.583%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil